[1] Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis?B disease, China. Bull World Health Organ,2019,97(3):230-238.
[2] Loomba R, Liang TJ. Hepatitis B. Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.Gastroenterology,2017,152(6):1297-1309.
[3] Federico A, Brancaccio G, Dallio M, et al. Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required??Dig Liver Dis,2017,49(2):197-201.
[4] Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci,2020,12(1):8.
[5] Aoki J, Kowazaki Y, Ohtsuki T, et al. Kinetics of peripheral hepatitis B virus-specific CD8+ T cells in patients with onset of viral reactivation.J Gastroenterol, 2013,48(6):728-737. |
